Corrigendum: Recent Advances in Lentiviral Vaccines for HIV-1 Infection
- 1Department of Medicine, Division of Infectious Diseases, NYU School of Medicine, New York, NY, USA
- 2Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA
A corrigendum on
In the original article, an error in the references in the section entitled “Addressing Safety Concerns with LV Vaccine Vectors” is present. Reference number 20 which is cited twice in this section is an error and should instead be Di Nunzio et al. (1).
The authors apologize for this. This error does not change the scientific conclusions of the article in any way.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Keywords: dendritic cells, lentiviral vectors, HIV-1, HIV-1 vaccines, SAMHD1, Vpx
Citation: Norton TD and Miller EA (2016) Corrigendum: Recent Advances in Lentiviral Vaccines for HIV-1 Infection. Front. Immunol. 7:354. doi: 10.3389/fimmu.2016.00354
Received: 04 August 2016; Accepted: 31 August 2016;
Published: 14 September 2016
Edited and Reviewed by: Mario Clerici, University of Milan, Italy
Copyright: © 2016 Norton and Miller. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Elizabeth A. Miller, email@example.com